![eloralintide vs cagrilintide Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial PDF] Once-weekly cagrilintide for weight](https://www.thelancet.com/cms/10.1016/S0140-6736(25)02155-5/asset/fbf43461-d7e3-4b2b-9776-9027045a3823/main.assets/gr1_lrg.jpg)
eloralintide vs cagrilintide
Shipping Estimate
eloralintide vs cagrilintide Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial PDF] Once-weekly cagrilintide for weight
USD22.59
USD42.59
Pay in 4 interest-free payments of $5.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
![eloralintide vs cagrilintide Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial PDF] Once-weekly cagrilintide for weight](https://figures.semanticscholar.org/a9800c8f0dc40d6d18a09ab6d2f14e71a42af380/5-Table1-1.png)
![eloralintide vs cagrilintide Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial PDF] Once-weekly cagrilintide for weight](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3939128847122505068)
![eloralintide vs cagrilintide Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial PDF] Once-weekly cagrilintide for weight](https://framerusercontent.com/images/CgvVauL4J2F2nRPtRp74yO4tag.png)
![eloralintide vs cagrilintide Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial PDF] Once-weekly cagrilintide for weight](https://static.biospace.com/dims4/default/5efc022/2147483647/strip/true/crop/4174x2348+0+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F3c%2F60%2F6e82c28543fc9c379be48538553c%2Fistock-2149249887.jpg)
![eloralintide vs cagrilintide Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial PDF] Once-weekly cagrilintide for weight](https://www.noom.com/tachyon/2026/04/eloralintide-weight-loss-blog-scaled.jpg)